Intravesical adoptive cell therapy using tumor-infiltrating lymphocytes (TIL)

tumor-infiltrating lymphocytes (TIL) · H. Lee Moffitt Cancer Center and Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Intravesical adoptive cell therapy using tumor-infiltrating lymphocytes (TIL), covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Intravesical Adoptive Cell Therapy w/ TIL for BCG Exposed High Grade NMIBC [Phase 1]

See pricing